|

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

RECRUITINGN/ASponsored by Virginia Commonwealth University
Actively Recruiting
PhaseN/A
SponsorVirginia Commonwealth University
Started2026-05-20
Est. completion2026-07-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT07426913

Summary

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* 18 years of age or older
* Able to speak and read in English
* Actively receiving Trastuzumab or an anthracycline-based treatment
* Diagnosed with stages 0-III Breast Cancer

Exclusion Criteria:

\- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)

Conditions5

Anthracycline Related Cardiotoxicity in Breast CancerBreast CancerCancerTrastuzumabVirtual Reality

Locations3 sites

Adult Outpatient Pavilion
Richmond, Virginia, 23220
Victoria Williams804-827-7363williamsv4@vcu.edu
Cellular Immunotherapies and Transplant Department
Richmond, Virginia, 23220
Victoria Williams804-827-7363williamsv4@vcu.edu
VCU Health at Stony Point
Richmond, Virginia, 23223
Victoria Williams804-827-7363williamsv4@vcu.edu

Find trials near these locations

All trials in Virginia

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.